INS and hepatocellular carcinoma: As the main target organ of insulin, any pathological processes such as inflammation or neoplasia occur in the liver, will block the insulin signaling pathway and cause IR, which has been shown to be an independent risk factor accelerating the progression of HCC (Farrell, 2014).